Baxter (BAX) Misses Q2 EPS by 2c; offers guidance

Baxter (NYSE: BAX) reported Q2 EPS of $0.59, $0.02 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $2.82 billion.

GUIDANCE:

Baxter sees Q3 2025 EPS of $0.58-$0.62, versus the consensus of $0.64.

Baxter sees FY2025 EPS of $2.42-$2.52, versus the consensus of $2.52.

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• DOJ Unveils $6.5B Healthcare Fraud Crackdown - WSJ
• Italy's Meloni seeks to normalize US relations after Trump spat